| 颜艳 王爽 苏爱军 李琳 张毅 李全民.厄贝沙坦联合氨氯地平治疗2 型糖尿病合并高血压的疗效及对糖代谢和
血压的影响[J].,2015,15(21):4149-4152 |
| 厄贝沙坦联合氨氯地平治疗2 型糖尿病合并高血压的疗效及对糖代谢和
血压的影响 |
| Effect of Irbesartan Plus Amlodipine in Treatment of Type 2 DiabetesMellitus Combined with Hypertension |
| |
| DOI： |
| 中文关键词: 厄贝沙坦 氨氯地平 2 型糖尿病 高血压 |
| 英文关键词: Irbesartan Amlodipine Type 2 diabetes mellitus Hypertension |
| 基金项目: |
|
| 摘要点击次数: 465 |
| 全文下载次数: 0 |
| 中文摘要: |
| 目的：探索厄贝沙坦联合氨氯地平治疗2型糖尿病合并高血压的疗效及对糖代谢和血压的影响。方法：选择2013年7 月至
2014 年8月期间我院收治的2 型糖尿病合并高血压患者50 例，根据随机数字表法，将患者分成联合用药组和美托洛尔组。联合
用药组口服厄贝沙坦和氨氯地平；美托洛尔组口服美托洛尔，疗程为3个月。分析比较治疗前后两组患者的空腹血糖（FBG）、空腹
胰岛素（FINS）、胰岛素敏感指数（HOMA-IR）、收缩压（SBP）和舒张压（DBP）水平之间的差异，观察临床疗效。结果：治疗后，两组
患者FBG、FINS、HOMA-IR、SBP和DBP 水平较治疗前均有所下降，其中联合用药组下降得更明显（P<0.05），且治疗后联合用药
组上述指标均显著低于美托洛尔组，差异均有统计学意义（P<0.05）。治疗后，联合用药组的治疗有效率为88.00%，显著高于美托
洛尔组的48.00%，且差异具有统计学意义（P<0.05）。结论：厄贝沙坦联合氨氯地平治疗2 型糖尿病合并高血压患者具有良好的疗
效，可以改善血糖和血压情况，对于指导临床用药具有重要意义。 |
| 英文摘要: |
| Objective:To explore the effect of irbesartan plus amlodipine in the treatment of type 2 diabetes mellitus combined
with hypertension and their influence on glucose metabolism and blood pressure.Methods:A total of 50 patients with type 2 diabetes
mellitus combined with hypertension, who were admitted to Second Artillery General Hospital of Beijing fromJuly 2013 to August 2014,
were randomly divided into combination group and metoprolol group. The combination group was treated with irbesartan plus amlodipine,
while the metoprolol group was treated with metoprolol, the course of treatment was 3 months. Then the levels of fasting blood glucose(
FBG), fasting insulin(FINS), insulin sensitive index(HOMA-IR), systolic blood pressure(SBP) and diastolic blood pressure(DBP)
before and after treatment were compared between the two groups, the clinical effects were observed.Results:Compared with before
treatment, the levels of FBG, FINS, HOMA IR, SBP and DBP in the two groups after treatment all decreased, the levels of the above indexes
in the combination group after treatment were statistically lower than those in the metoprolol group, the differences were statistically
significant (P<0.05). The total effective rate(88.00%) in combination group was significantly higher than that(48.00%) in metoprolol
group after treatment, the difference was statistically significant (P<0.05).Conclusion:Irbesartan plus amlodipine has a good effect in the
treatment of type 2 diabetes mellitus combined with hypertension and can improve the blood glucose and blood pressure conditions,
which has an important significance for guiding the clinical medication. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
